About EARL​

The European Association of Nuclear Medicine (EANM), with its central role in the scientific community and its professional setup, today constitutes the umbrella organisation for nuclear medicine in Europe. In 2006, the leadership of the EANM launched EANM Forschungs GmbH (EARL) as an initiative to promote harmonized quantification in nuclear medicine imaging.

EARL was created to unleash the power of molecular imaging and further:

To act as a contact point for researchers as well as for clinicians and business leaders

To provide basis for discussion and the exchange of cutting edge ideas

To improve nuclear medicine and its practice

EARL can accredit your PET/CT scanner

To give a platform for the efficient pursuit of scientific initiatives

To enhance the comparability of data acquired by molecular imaging

To boost molecular imaging so that it becomes a standard diagnostic modality in future clinical medicine and research

To position nuclear medicine within the EU research agenda